Pevaryl (Econazole Nitrate)

What Is Pevaryl and What Is It Used For?

Pevaryl (econazole nitrate) is a topical antifungal medication belonging to the imidazole class, primarily used to treat athlete's foot (tinea pedis) and other superficial fungal skin infections. It works by inhibiting ergosterol synthesis in fungal cell membranes, leading to cell death.

Econazole nitrate, the active ingredient in Pevaryl, was first developed in the 1970s and has since become one of the most widely used topical antifungal agents worldwide. It belongs to the imidazole class of antifungals, which also includes drugs such as clotrimazole, miconazole, and ketoconazole. Pevaryl is available in two main formulations: a 1% cream for topical application on the skin and a 150 mg vaginal pessary (Pevaryl Depot) for the treatment of vaginal candidiasis.

The mechanism of action of econazole nitrate involves the inhibition of the enzyme lanosterol 14-alpha-demethylase (CYP51), a cytochrome P450 enzyme essential for converting lanosterol to ergosterol. Ergosterol is a critical component of fungal cell membranes, analogous to cholesterol in human cell membranes. When ergosterol synthesis is blocked, the fungal cell membrane becomes increasingly permeable, ultimately leading to leakage of cellular contents and death of the fungal cell.

Pevaryl demonstrates broad-spectrum antifungal activity against a wide range of pathogenic fungi. It is particularly effective against dermatophytes (such as Trichophyton, Microsporum, and Epidermophyton species), yeasts (including Candida albicans and other Candida species), and even certain gram-positive bacteria. This broad spectrum of activity makes it suitable for treating mixed infections where both fungal and bacterial organisms may be involved.

The primary indication for Pevaryl cream is athlete's foot (tinea pedis), a common fungal infection affecting the feet, particularly between the toes. However, healthcare providers may also prescribe or recommend it for other dermatophyte infections including tinea corporis (ringworm of the body), tinea cruris (jock itch), and cutaneous candidiasis. The vaginal pessary formulation is used specifically for vulvovaginal candidiasis (vaginal thrush).

What Should You Know Before Using Pevaryl?

Before using Pevaryl, ensure you are not allergic to econazole nitrate or any of its ingredients. Use caution during pregnancy (especially the first trimester) and inform your healthcare provider about all medications you are taking, particularly blood-thinning drugs such as warfarin.

Contraindications

Pevaryl should not be used if you have a known allergy (hypersensitivity) to econazole nitrate or to any of the other ingredients in the formulation. Allergic reactions to imidazole antifungals, while uncommon, can include contact dermatitis, urticaria (hives), and in rare cases, angioedema. If you have previously experienced an allergic reaction to other imidazole or azole antifungals such as clotrimazole, miconazole, or ketoconazole, discuss this with your healthcare provider before using Pevaryl, as cross-sensitivity may occur.

Pevaryl is intended for external use only and should not be applied to the eyes, mouth, or other internal surfaces. When applying the cream, take care to avoid contact with the eyes. Wash your hands thoroughly after each application to prevent inadvertent transfer of the medication to sensitive areas. The exception to this rule is when you have been prescribed treatment specifically for your hands – in this case, do not wash your hands immediately after application.

Warnings and Precautions

The cream formulation of Pevaryl contains benzoic acid (E 210) and butylated hydroxyanisole (BHA) as excipients. Benzoic acid can cause local skin irritation in some individuals and may increase the risk of jaundice (yellowing of the skin and eyes) in newborn infants up to 4 weeks of age. Therefore, Pevaryl cream should be used with caution in neonates, and parents should consult a healthcare provider before applying it to very young infants.

Butylated hydroxyanisole (BHA) is an antioxidant preservative that may cause local skin reactions such as contact eczema or irritation to the eyes and mucous membranes in sensitive individuals. If you have a known sensitivity to BHA, you should be aware of its presence in the cream formulation and monitor for any signs of skin irritation when beginning treatment.

If the infection does not show signs of improvement within 7 days of starting treatment, you should discontinue use and consult a healthcare provider. Persistent or worsening symptoms may indicate a different type of infection that requires alternative treatment, or an underlying condition that predisposes to fungal infections and needs separate evaluation.

Pregnancy and Breastfeeding

The use of Pevaryl during pregnancy requires careful consideration and should always be discussed with a healthcare provider. During the first trimester, Pevaryl should only be used if specifically recommended by a doctor, as this is the period when the fetus is most vulnerable to potential teratogenic effects. Although topical econazole has limited systemic absorption, the precautionary principle applies during early pregnancy.

During the second and third trimesters, Pevaryl may be used if the potential benefit to the mother outweighs the possible risks to the fetus. Studies have not demonstrated significant teratogenic effects with topical econazole use in pregnancy, but the available data is limited. Your healthcare provider will assess your individual circumstances and determine whether treatment is appropriate.

It is currently unknown whether econazole nitrate passes into breast milk when applied topically. While systemic absorption from topical application is generally minimal, nursing mothers should consult their healthcare provider before using Pevaryl. If treatment is deemed necessary, avoid applying the cream to the breast area to prevent direct exposure of the infant during breastfeeding.

Effects on Driving and Operating Machinery

Pevaryl has no known effects on the ability to drive or operate machinery. As a topical medication with minimal systemic absorption, it does not cause drowsiness, dizziness, or any other effects that could impair your ability to safely drive or use machines.

How Does Pevaryl Interact with Other Drugs?

Pevaryl may interact with anticoagulant medications such as warfarin and acenocoumarol, potentially enhancing their blood-thinning effects. Although systemic absorption from topical application is limited, this interaction may increase bleeding risk. Always inform your healthcare provider about all medications you are using.

Drug interactions with topical econazole are less common than with oral azole antifungals, primarily because topical application results in limited systemic absorption. However, clinically significant interactions have been documented, particularly with anticoagulant medications. The most important interaction to be aware of involves blood-thinning drugs belonging to the coumarin class.

Econazole, like other azole antifungals, has the potential to inhibit cytochrome P450 enzymes in the liver, particularly CYP2C9 and CYP3A4. These enzymes are responsible for metabolizing warfarin and other coumarin anticoagulants. When econazole inhibits these enzymes, the metabolism of warfarin slows down, leading to higher blood levels of the anticoagulant and an increased risk of bleeding complications. Although the extent of this interaction is typically less pronounced with topical econazole compared to oral azole antifungals, it is still clinically relevant, particularly when the cream is applied over large body surface areas or for extended periods.

Patients receiving warfarin therapy who need to use Pevaryl should have their International Normalised Ratio (INR) monitored more frequently during treatment. Signs of excessive anticoagulation include unusual bruising, nosebleeds, blood in the urine or stool, and prolonged bleeding from cuts. If you experience any of these symptoms while using Pevaryl concurrently with an anticoagulant, seek medical attention immediately.

Beyond anticoagulants, inform your healthcare provider or pharmacist about all other medications you are using, including prescription drugs, over-the-counter products, and herbal supplements. While no other clinically significant interactions have been widely documented with topical econazole, your healthcare provider can provide personalized guidance based on your complete medication profile.

What Is the Correct Dosage of Pevaryl?

For athlete's foot, apply Pevaryl 1% cream to the affected area twice daily (morning and evening) after washing and drying the feet. Continue treatment for at least 2 weeks after symptoms resolve. Children under 10 years should not be treated without medical supervision.

Adults

For the treatment of athlete's foot in adults, Pevaryl 1% cream should be applied to the infected skin twice daily – once in the morning and once in the evening. Before applying the cream, wash the affected area thoroughly with soap and water, then dry it completely, paying particular attention to the spaces between the toes. Gently massage a thin layer of cream into the affected skin and the immediately surrounding area.

Good foot hygiene is essential for successful treatment. Wear breathable socks made from natural fibres such as cotton or wool, and change them daily. Choose well-ventilated shoes and avoid wearing the same pair of shoes on consecutive days to allow them to dry thoroughly. These hygiene measures not only support the effectiveness of treatment but also help prevent reinfection.

If you have been prescribed treatment for your hands, it is recommended to reapply the cream after each time you wash your hands. This ensures that the medication maintains adequate contact time with the infected skin to exert its antifungal effect.

Children

Children under 10 years of age should not be treated with Pevaryl without a prescription from a healthcare provider. The safety and efficacy of econazole nitrate in very young children have not been extensively studied, and a healthcare provider should assess whether the infection requires treatment and determine the appropriate approach. For children aged 10 and above, the dosage and method of application are the same as for adults.

Elderly Patients

No specific dosage adjustment is required for elderly patients. The same dosing regimen as for adults applies. However, elderly patients may have thinner, more fragile skin and may be more susceptible to local irritation. If excessive irritation occurs, reduce the frequency of application or consult a healthcare provider. Elderly patients taking anticoagulants should be particularly vigilant about the potential warfarin interaction discussed above.

Missed Dose

If you forget to apply Pevaryl at the scheduled time, apply it as soon as you remember. However, do not apply a double dose to make up for the missed application. Simply continue with your regular dosing schedule. Consistency of application is important for the effectiveness of the treatment, so try to apply the cream at roughly the same times each day.

Overdose

Topical overdose with Pevaryl cream is unlikely to cause serious systemic effects due to the limited absorption through the skin. If the cream is accidentally ingested, particularly by a child, contact a poison control centre or seek medical advice for an assessment of risk. If Pevaryl gets into the eyes, flush immediately with clean water or saline solution and seek medical attention if irritation persists.

Pevaryl cream does not stain clothing or skin and can be easily washed off with soap and water. This makes it practical for daily use without concerns about staining garments or bed linens.

What Are the Side Effects of Pevaryl?

The most common side effects of Pevaryl are itching, burning, and pain at the application site, occurring in more than 1 in 100 users. Serious side effects are rare but include allergic reactions such as angioedema. Stop using Pevaryl and seek immediate medical help if you experience facial swelling, difficulty breathing, or widespread hives.

Like all medicines, Pevaryl can cause side effects, although not everybody experiences them. The side effects associated with topical econazole nitrate are predominantly local reactions at the site of application. Systemic side effects are extremely rare due to the limited absorption of the drug through the skin. Most side effects are mild and resolve on their own as the body adapts to the medication or after treatment is completed.

Understanding the frequency classifications used in reporting side effects helps put the risk in perspective. Side effects are categorised as very common (affects more than 1 in 10 users), common (affects 1 to 10 in 100 users), uncommon (affects 1 to 10 in 1,000 users), rare (affects 1 to 10 in 10,000 users), and frequency not known (cannot be estimated from available data).

The majority of local side effects – itching, burning, and mild pain – are usually transient and tend to diminish as treatment continues. These reactions are often related to the initial contact of the medication with inflamed or broken skin at the infection site. If these symptoms are severe, persistent, or worsen over time, discontinue use and consult a healthcare provider.

Contact dermatitis is an allergic skin reaction that can develop in some individuals following repeated exposure to econazole nitrate or one of the excipients in the cream formulation. If you notice a rash that spreads beyond the treated area, or if the treated area becomes increasingly red, swollen, and itchy despite treatment, this may indicate contact dermatitis rather than the original infection worsening. In this case, stop treatment and seek medical advice.

If you experience any side effects, whether listed here or not, report them to your healthcare provider, pharmacist, or nurse. Reporting of suspected adverse reactions after authorisation of the medicine is important, as it allows continuous monitoring of the medicine's benefit-risk balance.

How Should You Store Pevaryl?

Store Pevaryl cream below 25°C (77°F) and keep the tube tightly closed. Keep all medicines out of the sight and reach of children. Do not use after the expiry date printed on the packaging.

Proper storage of medications ensures they remain effective and safe throughout their shelf life. Pevaryl cream should be stored at a temperature not exceeding 25°C (77°F). While brief exposure to higher temperatures is unlikely to significantly affect the product, prolonged storage in warm conditions may alter the consistency or stability of the cream formulation. Do not freeze the cream.

Keep the tube tightly closed when not in use to prevent contamination and drying out of the cream. Store the product in its original packaging to protect it from light. After opening, the cream should be used within the timeframe specified on the packaging or within a reasonable period, typically within 6 months.

Always keep medicines out of the sight and reach of children. Do not use Pevaryl after the expiry date stated on the tube and outer carton. The expiry date refers to the last day of the stated month. Do not dispose of medicines via the wastewater system or household waste. Ask your pharmacist about how to properly dispose of medicines no longer needed, as these measures help protect the environment.

What Does Pevaryl Contain?

The active ingredient in Pevaryl is econazole nitrate (1% in cream formulation). The cream also contains excipients including benzoic acid, butylated hydroxyanisole (BHA), liquid paraffin, and purified water. The composition varies between cream and powder formulations.

Pevaryl 1% Cream

The cream formulation contains econazole nitrate as the active ingredient at a concentration of 1% (10 mg/g). The excipients (inactive ingredients) that form the cream base include:

• Benzoic acid (E 210): A preservative that helps prevent microbial contamination. May cause local irritation in sensitive individuals. Contains 2 mg/g.
• Butylated hydroxyanisole (BHA): An antioxidant that prevents degradation of the active ingredient. May cause local skin reactions (contact eczema) or irritation to eyes and mucous membranes in sensitive individuals.
• Pegoxol 7 stearate: An emulsifying agent that helps maintain the cream consistency.
• Oleoyl macrogolglycerides: Emulsifiers that contribute to the smooth texture of the cream.
• Liquid paraffin: A moisturising agent that provides a smooth, non-greasy application.
• Purified water: The base solvent for the cream formulation.

The cream is white in colour with a faint odour and is supplied in aluminium tubes containing 30 g, 70 g, or 78 g of product. Not all pack sizes may be available in every market.

Appearance and Pack Sizes

Pevaryl 1% cream is a smooth, white cream that spreads easily and is absorbed without leaving a greasy residue on the skin. It does not stain clothing or skin and can be washed off with soap and water. The vaginal pessary (Pevaryl Depot, 150 mg) is a smooth, white to off-white ovule designed for intravaginal administration.